186 related articles for article (PubMed ID: 18403592)
1. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC
Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
Christacos NC; Quade BJ; Dal Cin P; Morton CC
Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
5. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
Ordulu Z; Nucci MR; Dal Cin P; Hollowell ML; Otis CN; Hornick JL; Park PJ; Kim TM; Quade BJ; Morton CC
Mod Pathol; 2016 May; 29(5):500-10. PubMed ID: 26892441
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.
Gross KL; Neskey DM; Manchanda N; Weremowicz S; Kleinman MS; Nowak RA; Ligon AH; Rogalla P; Drechsler K; Bullerdiek J; Morton CC
Genes Chromosomes Cancer; 2003 Sep; 38(1):68-79. PubMed ID: 12874787
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of calponin h1 in leiomyosarcoma of the uterus.
Horiuchi A; Nikaido T; Ito K; Zhai Y; Orii A; Taniguchi S; Toki T; Fujii S
Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
[TBL] [Abstract][Full Text] [Related]
9. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
10. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hodge JC; Morton CC
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
[TBL] [Abstract][Full Text] [Related]
13. CD56 is Expressed in Uterine Smooth Muscle Tumors.
Karpathiou G; Chauleur C; Papoudou-Bai A; Dagher S; Peoc'h M
Int J Gynecol Pathol; 2021 Jul; 40(4):315-323. PubMed ID: 32897962
[TBL] [Abstract][Full Text] [Related]
14. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
Fletcher JA; Morton CC; Pavelka K; Lage JM
Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
[TBL] [Abstract][Full Text] [Related]
15. Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.
Hodge JC; Park PJ; Dreyfuss JM; Assil-Kishawi I; Somasundaram P; Semere LG; Quade BJ; Lynch AM; Stewart EA; Morton CC
Genes Chromosomes Cancer; 2009 Oct; 48(10):865-85. PubMed ID: 19603527
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation.
Mas A; Cervelló I; Fernández-Álvarez A; Faus A; Díaz A; Burgués O; Casado M; Simón C
Mol Hum Reprod; 2015 Apr; 21(4):330-8. PubMed ID: 25542836
[TBL] [Abstract][Full Text] [Related]
17. HMGA proteins regulate the expression of FGF2 in uterine fibroids.
Helmke BM; Markowski DN; Müller MH; Sommer A; Müller J; Möller C; Bullerdiek J
Mol Hum Reprod; 2011 Feb; 17(2):135-42. PubMed ID: 20926602
[TBL] [Abstract][Full Text] [Related]
18. Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature.
McDonald AG; Dal Cin P; Ganguly A; Campbell S; Imai Y; Rosenberg AE; Oliva E
Am J Surg Pathol; 2011 Feb; 35(2):221-7. PubMed ID: 21263242
[TBL] [Abstract][Full Text] [Related]
19. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract][Full Text] [Related]
20. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
